Osteoporosis is now being recognized as a ''silent epidemic'' and ther
e is an increasing need to improve its diagnosis and management. Quant
itative ultrasound (QUS) measurement [broadband ultrasound attenuation
(BUA) and velocity] is emerging as an alternative to photon absorptio
metry techniques in the assessment of osteoporosis. The fundamental pr
inciples governing ultrasound measurements are discussed, and some of
the commercially available clinical systems are reviewed, particularly
in relation to data acquisition methods. A review of the published in
vivo and in vitro data is presented. The general consensus is that ul
trasound seems to provide structural information in addition to densit
y. The diagnostic sensitivity of ultrasound measurement of the calcane
us in the prediction of hip fracture has been shown by recent large pr
ospective studies to be similar to hip bone mineral density (BMD) meas
ured with dual-energy X-ray absorptiometry (DXA) and superior to spine
BMD. Ultrasound has also been shown to correlate better with the type
of hip fracture (intertrochanteric or cervical) than BMD and to provi
de comparable diagnostic sensitivity to spine BMD in vertebral fractur
es. It has also been observed that combining the results of both ultra
sound and DXA BMD significantly improved hip fracture prediction. Area
s where further research is required are identified.